Ameritas Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Ameritas Advisory Services’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-150	Closed	-$24.9K	–	1019
2025 Q3	$24.9K	Sell	150 -221	-60%	-$36K	﹤0.01%	1367
2025 Q2	$56.9K	Buy	+371	New	+$55.3K	﹤0.01%	1245
2023 Q2	–	Sell	-371	Closed	-$60.6K	–	708
2023 Q1	$60.6K	Buy	+371	New	+$60K	﹤0.01%	1196

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

Ameritas Advisory Services's BBH Position: Q4 2025 in Review

Ameritas Advisory Services sold out of VanEck Biotech ETF (BBH) in Q4 2025, closing a stake of 150 shares — an estimated $24.9K sold.

Ameritas Advisory Services first reported a position in BBH in Q1 2023 and held it in 3 quarters. The position peaked at $60.6K in Q1 2023. 111 funds tracked by Wall St. Rank hold BBH as of Q4 2025.

Ameritas Advisory Services reported no remaining VanEck Biotech ETF position as of Q4 2025 after selling out during the quarter.
Ameritas Advisory Services sold 150 VanEck Biotech ETF shares in Q4 2025, an estimated $24.9K.
Ameritas Advisory Services first reported a position in VanEck Biotech ETF in Q1 2023 and held it in 3 quarters.
Ameritas Advisory Services's VanEck Biotech ETF position peaked at $60.6K in Q1 2023.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.